These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 21874883)

  • 1. [Prevention of recurrence of benign ovarian tumors in women of reproductive age after urgent operations].
    Dmitrishen RA; Tsygan VN; Dolgov GV
    Voen Med Zh; 2011 May; 332(5):36-41. PubMed ID: 21874883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Frequency of recurrence and repeated development of ovarian tumors after conservative operations].
    Utkin IuK
    Vopr Onkol; 1981; 27(3):29-32. PubMed ID: 7222519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Borderline ovarian tumors in reproductive-age women. Fertility-sparing surgery and outcome.
    Chan JK; Lin YG; Loizzi V; Ghobriel M; DiSaia PJ; Berman ML
    J Reprod Med; 2003 Oct; 48(10):756-60. PubMed ID: 14619640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcomes following conservative surgery for borderline tumor of the ovary: a large population-based study.
    Suh-Burgmann E
    Gynecol Oncol; 2006 Dec; 103(3):841-7. PubMed ID: 16793124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fertility after conservative treatment for borderline ovarian tumors: a French multicenter study.
    Fauvet R; Poncelet C; Boccara J; Descamps P; Fondrinier E; Daraï E
    Fertil Steril; 2005 Feb; 83(2):284-90; quiz 525-6. PubMed ID: 15705364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hormonally-active ovarian tumors in 30 years of data (1965-1994)].
    Molnar E; Sloboda L; Fenjvesi A; Zivković S
    Med Pregl; 1999; 52(6-8):241-5. PubMed ID: 10518380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restaging surgery for women with borderline ovarian tumors: results of a French multicenter study.
    Fauvet R; Boccara J; Dufournet C; David-Montefiore E; Poncelet C; Daraï E
    Cancer; 2004 Mar; 100(6):1145-51. PubMed ID: 15022280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conservative surgery to preserve ovarian function in patients with malignant ovarian germ cell tumors. A review of 74 cases.
    Low JJ; Perrin LC; Crandon AJ; Hacker NF
    Cancer; 2000 Jul; 89(2):391-8. PubMed ID: 10918171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The system of rehabilitation of specific functions of the female body of patients with benign ovarian neoplasm after urgent operations].
    Dmitrishen RA; Tsygan VN; Dolgov GV
    Voen Med Zh; 2011 Jun; 332(6):34-8. PubMed ID: 21899077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Assisted reproductive technologies after conservative management of borderline or invasive ovarian tumours].
    Fortin A; Hazout A; Thoury A; Alvès K; Bats AS; Dhainaut C; Madelenat P
    Gynecol Obstet Fertil; 2005; 33(7-8):488-97. PubMed ID: 16019249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fertility and recurrence results of conservative surgery for borderline ovarian tumors.
    Boran N; Cil AP; Tulunay G; Ozturkoglu E; Koc S; Bulbul D; Kose MF
    Gynecol Oncol; 2005 Jun; 97(3):845-51. PubMed ID: 15896834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
    Silva EG; Gershenson DM; Malpica A; Deavers M
    Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of simple cystectomy in patients with unilateral mucinous borderline tumors.
    Salomon LJ; Lhommé C; Pautier P; Duvillard P; Morice P
    Fertil Steril; 2006 May; 85(5):1510.e1-4. PubMed ID: 16647380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pediatric ovarian tumors--dilemmas in diagnosis and management.
    Ruttenstock EM; Saxena AK; Schwinger W; Sorantin E; Hoellwarth ME
    Eur J Pediatr Surg; 2010 Mar; 20(2):116-20. PubMed ID: 20112185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Analysis of prognostic factors of malignant ovarian tumor after fertility-preserving treatment].
    Zeng DY; Shen K; Huang HF; Wu M; Pan LY; Yang JX; Lang JH
    Zhonghua Yi Xue Za Zhi; 2005 Sep; 85(36):2562-5. PubMed ID: 16321304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Reasons for repeat operations in patients with tumors of the ovaries].
    Mitrokhina MV; Iurkova LE
    Vopr Onkol; 1988; 34(6):725-9. PubMed ID: 3394273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pregnancy outcome and recurrence after conservative laparoscopic surgery for borderline ovarian tumors.
    Tinelli FG; Tinelli R; La Grotta F; Tinelli A; Cicinelli E; Schönauer MM
    Acta Obstet Gynecol Scand; 2007; 86(1):81-7. PubMed ID: 17230294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of incidental ovarian tumors in patients undergoing gastric bypass.
    Gonzalez R; Haines K; Gallagher SF; Sanders G; Hoffman M; Murr MM
    Obes Surg; 2004 Oct; 14(9):1216-21. PubMed ID: 15527637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrence and prognostic factors in borderline ovarian tumors.
    Ayhan A; Guvendag Guven ES; Guven S; Kucukali T
    Gynecol Oncol; 2005 Sep; 98(3):439-45. PubMed ID: 16009407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovarian intestinal type mucinous borderline tumors: are we ready for a nomenclature change?
    Chiesa AG; Deavers MT; Veras E; Silva EG; Gershenson D; Malpica A
    Int J Gynecol Pathol; 2010 Mar; 29(2):108-12. PubMed ID: 20173495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.